ST. PAUL, Minn., May 14, 2025 - In a significant boost to cell and gene therapy research, ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady, has awarded three G-Rex Grants totaling $1,025,000 to faculty members at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA). These grants aim to support the translation of various cell and gene therapy initiatives into clinical applications. Notable recipients include Dr. Mohamed Abou-el-Enein, who secured $300,000 to advance a novel non-viral CAR-T cell therapy manufacturing platform, and Dr. Shahab Asgharzadeh, who received $250,000 for preclinical development of a new CAR-T cell therapy for solid tumors. Dr. Preet Chaudhary was awarded $200,000 for synthetic immune receptor engineered T cell therapy process development. The funding is set to enhance CAR-T manufacturing and contribute to cutting-edge therapeutic solutions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。